The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Cardiovascular and other comorbidities in patients with psoriatic arthritis: A comparison with patients with psoriasis
Abstract
Objective: To determine whether the presence of psoriatic arthritis (PsA) is associated with greater comorbidity, in particular cardiovascular morbidity, compared to psoriasis without arthritis. Methods: Six hundred eleven patients with PsA were recruited from the University of Toronto Psoriatic Arthritis Clinic and 449 psoriasis without arthritis patients were recruited from the University of Toronto Psoriasis Cohort. The clinical database was used to identify the prevalence of cardiovascular and other comorbidities in both PsA and psoriasis without arthritis patients. Univariate and multivariate logistic regression analyses were conducted to estimate odds ratios (ORs), comparing the odds of ever having a given comorbid disease in PsA patients with those in psoriasis without arthritis patients. Covariates included age, sex, education, smoking status, severity and duration of psoriasis, medication status, and other comorbidities. Results: The prevalence of hypertension, obesity, hyperlipidemia, type 2 diabetes mellitus, and at least 1 cardiovascular event in PsA patients was 37.1%, 30.0%, 20.7%, 12.0%, and 8.2%, respectively. This was significantly higher than in psoriasis without arthritis patients, with unadjusted ORs ranging from 1.54 to 2.59. In the multivariate analyses, hypertension remained significantly elevated (adjusted OR 2.17). PsA was also significantly associated with infections not treated with antibiotics (presumably viral), neurologic conditions, gastrointestinal disorders, and liver disease (adjusted ORs 2.83, 4.76, 21.53, and 7.74, respectively). Infections treated with antibiotics and depression/anxiety were relatively common in PsA, with a prevalence of 30.5% and 20.7%, respectively. However, this was not significantly different from psoriasis without arthritis after multivariate adjustments. Conclusion: The results suggest that inflammatory joint disease may play a role in both cardiovascular and noncardiovascular morbidity in PsA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogenesis and clinical features of psoriasis
Griffiths, C. E., & Barker, J. N. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61128-3 · Cited by 2,158
Risk of myocardial infarction in patients with psoriasis
Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · JAMA · doi:10.1001/jama.296.14.1735 · Cited by 1,899
The development of a comorbidity index with physical function as the outcome
GROLL, D., TO, T., BOMBARDIER, C., & WRIGHT, J. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.10.018 · Cited by 1,198
Gabriel, S. E., & Michaud, K. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2669 · Cited by 891
Han, C., Robinson, D., Hackett, M., Paramore, L. C., Fraeman, K. H., & BALA, M. M. (2006) · PubMed · Cited by 721
Psoriatic Arthritis (PSA) - An Analysis of 220 Patients
(1987) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068085 · Cited by 639
Abuabara, K., Azfar, R. S., Shin, D. B., Neimann, A. L., Troxel, A. B., & Gelfand, J. M. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09941.x · Cited by 472
Kimball, A. B., Gladman, D., Gelfand, J. M., Gordon, K., Horn, E. J., Korman, N. J., Korver, G., Krueger, G. G., Strober, B. E., & Lebwohl, M. G. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.01.006 · Cited by 432
Self-citationProdanovich, S., Kirsner, R. S., Kravetz, J. D., Ma, F., Martinez, L., & Federman, D. G. (2009) · Archives of Dermatology · doi:10.1001/archdermatol.2009.94 · Cited by 394
Cardiovascular morbidity in psoriatic arthritis
Gladman, D. D., Ang, M., Su, L., Tom, B. D. M., Schentag, C. T., & Farewell, V. T. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.094839 · Cited by 304
Self-citationTam, L.-S., Tomlinson, B., Chu, T. T.-W., Li, M., Leung, Y.-Y., Kwok, L.-W., Li, T. K., Yu, T., Zhu, Y.-E., Wong, K.-C., et al. (2008) · Rheumatology · doi:10.1093/rheumatology/ken090 · Cited by 257
Gottlieb, A. B., Chao, C., & Dann, F. (2008) · Journal of Dermatological Treatment · doi:10.1080/09546630701364768 · Cited by 216
Blood pressure in Canadian adults.
Wilkins, K., Campbell, N. R. C., Joffres, M. R., McAlister, F. A., Nichol, M., Quach, S., Johansen, H. L., & Tremblay, M. S. (2010) · PubMed · Cited by 215
Prevalence and Risk Factors of Atherosclerosis in Patients with Psoriatic Arthritis
Kimhi, O., Caspi, D., Bornstein, N. M., Maharshak, N., Gur, A., Arbel, Y., Comaneshter, D., Paran, D., Wigler, I., Levartovsky, D., et al. (2007) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2006.09.001 · Cited by 214
Assessment of Disease Progress in Psoriasis
Marks, R. (1989) · Archives of Dermatology · doi:10.1001/archderm.125.2.235 · Cited by 195
Christophers, E., Barker, J., Griffiths, C., Daudén, E., Milligan, G., Molta, C., Sato, R., & Boggs, R. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03463.x · Cited by 191
Tackling ischaemic heart disease in rheumatoid arthritis
Kitas, G. D. (2003) · Rheumatology · doi:10.1093/rheumatology/keg175 · Cited by 180
Zhang, Y., Holford, T. R., Leaderer, B. P., Zahm, S. H., Boyle, P., Morton, L. M., Zhang, B., Zou, K., Flynn, S. D., Tallini, G., et al. (2004) · Cancer Causes & Control · doi:10.1023/b:caco.0000027506.55846.5d · Cited by 152
Cardiovascular Disease and Risk Factors in Patients with Psoriasis and Psoriatic Arthritis
Tobin, A., Veale, D. J., FitzGerald, O., Rogers, S., Collins, P. M., O'Shea, D. B., & Kirby, B. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.090822 · Cited by 134
Do Canada and the United States Differ in Prevalence of Depression and Utilization of Services?
Vasiliadis, H., LESAGE, A. D., Adair, C. E., Wang, P. S., & Kessler, R. C. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.1.63 · Cited by 134
Schmitt, J. M., & Ford, D. (2009) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03537.x · Cited by 131
Comorbidities in Psoriasis Patients
Kim, N., Thrash, B., & Menter, A. (2010) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2010.01.002 · Cited by 126
Complexity of the Association Between Psoriasis and Comorbidities
Nijsten, T. E. C., & Wakkee, M. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.55 · Cited by 121
Psoriasis and cardiovascular disease
Vena, G. A., Vestita, M. G., & Cassano, N. (2010) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2010.01308.x · Cited by 107
Shields, M. E., & Tjepkema, M. (2006) · PubMed · Cited by 81
Psoriasis, the liver, and the gastrointestinal tract
Gisondi, P., Giglio, M. D., Cozzi, A., & Girolomoni, G. (2010) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2010.01310.x · Cited by 44
Managing Comorbid Disease in Patients with Psoriatic Arthritis
Husni, M. E., & Mease, P. J. (2010) · Current Rheumatology Reports · doi:10.1007/s11926-010-0112-3 · Cited by 32
Can early treatment with biologicals modify the natural history of comorbidities?
Vena, G. A., Vestita, M. G., & Cassano, N. (2010) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2010.01313.x · Cited by 28
Cited by
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
Mease, P. J., McInnes, I. B., Kirkham, B., Kavanaugh, A., Rahman, P., van der Heijde, D., Landewé, R., Nash, P., Pricop, L., Yuan, J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412679 · Cited by 746
Smolen, J. S., Braun, J., Dougados, M., Emery, P., FitzGerald, O., Helliwell, P., Kavanaugh, A., Kvien, T. K., Landewé, R., Luger, T., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203419 · Cited by 447
Stuart, P. E., Nair, R. P., Tsoi, L. C., Tejasvi, T., Das, S., Kang, H. M., Ellinghaus, E., Chandran, V., Callis-Duffin, K., Ike, R., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.10.019 · Cited by 319
Self-citationCardiovascular comorbidities in patients with psoriatic arthritis: a systematic review
Jamnitski, A., Symmons, D., Peters, M. J. L., Sattar, N., MciInnes, I., & Nurmohamed, M. T. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201194 · Cited by 276
Depression and anxiety in psoriatic disease: prevalence and associated factors
McDonough, E., Ayearst, R., Eder, L., Chandran, V., Rosen, C. F., Thavaneswaran, A., & Gladman, D. D. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.130797 · Cited by 250
Metadata
- Authors
- Husted, J. A., Thavaneswaran, A., Chandran, V., Eder, L., Rosen, C. F., Cook, R. J., & Gladman, D. D.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2011-11-29
- Volume
- 63
- Issue
- 12
- Pages
- 1729-1735
- ISSN
- 0893-7524 (ISSN-L)
- 2151-464X
- 2151-4658
- OpenAlex
- W1989931772
- Cited by
- 264
- References
- 28
- FWCI
- 11.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.